Boehringer Ingelheim in Spain consolidates its long-term alliance with SEMERGEN's Board of Directors, reaffirming its joint commitment to primary care.
Both entities, with over 70 years of collaboration, highlight their focus on the primary care physician in both the present and the future.
The collaboration focuses on promoting research among primary care health professionals and increasing the participation of family physicians in clinical trials.
They highlight the importance of the primary care specialty in the management of chronic diseases such as cardiovascular, metabolic, inflammatory, respiratory, and mental health conditions.
A joint emblematic project is "Ready to Research", aimed at providing primary care physicians with the tools and competencies necessary for clinical research.
Boehringer Ingelheim underscores its commitment to continuous physician training through co-creation projects with SEMERGEN, seeking to improve patient care and treatment, as well as strengthen healthcare equity in primary care in the context of the transformation of the healthcare system.
The company seeks to be a vital health agent to efficiently address the current and future challenges of healthcare in Spain.
With information from: Corresponsables.
Receive all industry news in our weekly newsletter Scientific Dialectics.